>ScienceDaily, MedicalNewsToday, Scirus, TherapeuticsDaily are reputable sites per se, and like any news service ala Reuters, UPI etc, can print sometimes erroneous articles…<
These articles are rarely erroneous—the problem with them is that they are rarely newsworthy. For instance, variable vs fixed dosing of ribavirin is a story that broke almost 1.5 years ago when SGP’s WIN-R study was completed (#msg-11283408).
A number of readers of this board—myself included—find it annoying to have old stories presented to the board are though they were new stories. Old stories with a new twist are always welcome, of course. However, in some cases, your posts are repetitions of old material with no new angle. If you can make a concerted effort to weed out such posts, it will be greatly appreciated. Regards, Dew
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”